ENZON PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enzon Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Enzon Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 74.2M shares, unchanged year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 74.2M 0 0% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 74.2M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 74.2M 0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 74.2M 0 0% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 74.2M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 74.2M 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 74.2M 0 0% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 74.2M 0 0% Dec 31, 2022 10-K 2024-03-20
Q3 2022 74.2M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 74.2M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 74.2M 0 0% Mar 31, 2022 10-Q 2022-04-26
Q4 2021 74.2M 0 0% Dec 31, 2021 10-K 2023-02-16
Q3 2021 74.2M +30M +67.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 74.2M +30M +67.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 74.2M +30M +67.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 74.2M +30M +67.9% Dec 31, 2020 10-K 2022-02-25
Q3 2020 44.2M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 44.2M 0 0% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 44.2M 0 0% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 44.2M 0 0% Dec 31, 2019 10-K 2021-02-23
Q3 2019 44.2M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 44.2M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 44.2M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 44.2M 0 0% Dec 31, 2018 10-K 2020-02-19
Q3 2018 44.2M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 44.2M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 44.2M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 44.2M 0 0% Dec 31, 2017 10-K 2019-02-21
Q3 2017 44.2M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 44.2M +348K +0.79% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 44.2M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 44.2M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 44.2M +32.2K +0.07% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 43.9M -316K -0.72% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 44.2M +32.2K +0.07% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 44.2M +40.1K +0.09% Dec 31, 2015 10-K 2017-03-24
Q3 2015 44.2M +40.1K +0.09% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 44.2M +57K +0.13% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 44.2M +88.6K +0.2% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 44.2M +88.6K +0.2% Dec 31, 2014 10-K 2016-03-21
Q3 2014 44.1M +74K +0.17% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 44.1M +394K +0.9% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 44.1M +378K +0.87% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 44.1M +412K +0.94% Dec 31, 2013 10-K 2015-03-05
Q3 2013 44.1M -1.14M -2.52% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 43.7M -3.81M -8.02% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 43.7M -4.58M -9.48% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 43.7M -4.62M -9.56% Dec 31, 2012 10-K 2014-03-14
Q3 2012 45.2M -3.07M -6.35% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 47.5M -3.09M -6.1% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 48.3M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 48.3M -10.5M -17.9% Dec 31, 2011 10-K 2013-03-18
Q3 2011 48.3M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 50.6M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 58.8M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.